In Treatment of Severe bacterial infections Simercetin 125mg Injection works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of the lungs (pneumonia) and urinary tract. It is given by a doctor or nurse into a vein and should not be self-administered. Simercetin 125mg Injection usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Consuming alcohol while taking Simercetin 125mg Injection may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Simercetin 125mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Simercetin 125mg Injection is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Simercetin 125mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Simercetin 125mg Injection is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Simercetin 125mg Injection may not be needed in these patients. Please consult your doctor.
There is limited information available on the use of Simercetin 125mg Injection in patients with liver disease. Please consult your doctor.
If you miss a dose of Simercetin 125mg Injection, consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Medipol Pharmaceuticals India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vostok & Wilcure Remedies || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: V.S. Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biochem Pharmaceutical Industries || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Anant Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Oyster Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Ridhima Biocare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Suzikem Drugs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Acron Pharmaceuticals || ₹14.5/tablet (25% cheaper)